MoonLake Immunotherapeutics
MLTX
#5363
Rank
โ‚น153.45 B
Marketcap
โ‚น1,836
Share price
-1.76%
Change (1 day)
-61.43%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2026 (TTM): -โ‚น22.31 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น21.48 Billion a decrease over its 2024 earnings that were of -โ‚น12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น22.31 Billion3.87%
2025 -โ‚น21.48 Billion79.14%
2024 -โ‚น12 Billion129.45%
2023 -โ‚น5.23 Billion-16.81%
2022 -โ‚น6.29 Billion